[EN] CHEMOKINE CCR5 RECEPTOR MODULATORS<br/>[FR] MODULATEURS DES RECEPTEURS CCR5 DE CHIMIOKINE
申请人:HOFFMANN LA ROCHE
公开号:WO2005075484A2
公开(公告)日:2005-08-18
This invention relates to piperidine derivatives of formulae (I) with substituents as defined herein useful in the treatment of a variety of disorders, including those in which the modulation of CCR5 receptors is implicated. More particularly, the present invention relates to 1-oxa-3,8-diaza-spiro[4.5]decan-2-one and 1-oxa-3,9-diaza-spiro[5.5]undecan-2-one compounds and related derivatives, to compositions containing and to uses of such derivatives. Disorders that may be treated or prevented by the present derivatives include HIV and genetically related retroviral infections (and the resulting acquired immune deficiency syndrome, AIDS), diseases of the immune system and inflammatory diseases.
Bassus; Pacheco; Cier, European Journal of Medicinal Chemistry, 1974, vol. 9, # 4, p. 416 - 423